Fundamental dimension Equity attribute | AMMXLeader $0.077▼-16.30% Cap $1.16MP/E 1.1x QuantScore46/100 | CNGAPeer $0.350.00% Cap $2.19MP/E -6.0x QuantScore37/100 | ENCCPeer $0.018▲+1.69% Cap $2.70MP/E -180.0x QuantScore27/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
38/100 |
50/100 |
83/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 21/100 | 26/100 | 25/100 |
Growth Revenue / earnings growth & margins | 25/100 | 4/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 1.1x | -6.0x | -180.0x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 2.3x | -3.2x | -84.2x |
Price / Sales | 0.1x | 0.7x | — |
Price / Free Cash Flow | -0.2x | -10.0x | — |
PEG ratio | 0.00 | 0.14 | -1.80 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 2 / 9 | 2 / 9 |
Altman Z-Score | 0.22 (Distress) | 1.50 (Distress) | -33.58 (Distress) |
Total debt / equity | 4.24 | 0.00 | 0.00 |
Quick ratio | 0.4x | 0.8x | — |
Interest coverage | 0.8x | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -6.3% | -30.4% | — |
Net income growth YoY | +197.1% | -193.0% | -70.0% |
Gross margin (TTM) | 20.6% | 27.3% | 0.0% |
Operating margin (FY) | 6.6% | -9.2% | — |
FCF margin (FY) | -5.6% | 1.4% | — |
5. Trailing price performancePrice change over period |
1M return | -29.0% | 0.0% | +7.1% |
3M return | -51.9% | 0.0% | +12.5% |
6M return | -52.5% | -5.4% | +100.0% |
Year to date | -31.3% | +20.7% | -21.7% |
1Y return | -36.9% | +29.6% | -60.9% |
3Y return | -55.7% | -45.1% | +17900.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.0997 +29.4% upside | $0.6587 +88.2% upside | $-0.1251 -795.2% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |